October 27, 2014

BIVI Recognizes Employees at Local Celebration for State Award

Last week Boehringer Ingelheim Vetmedica, Inc. (BIVI), received an award from the Missouri Chamber of Commerce and Missouri Life magazine as one of the six Best Places to Work in the state. The inaugural state competition awarded companies that demonstrated successful and positive workplace cultures at the 2014 Best Workplaces Conference in Columbia, Mo.

“Your company is outstanding, and it won for a variety of reasons, including your use of employee "pulse checks," allowing employees to bring issues forward anonymously if needed, open financial reports, 100% tuition programs, and both peer-to-peer as well as leader-employee recognition programs,” says Greg Wood, publisher of Missouri Life and Missouri Business magazines. “Your extensive training and development topics and strong benefits program also were recognized.”

“As we continue to expand our business and meet the demands of our customers, our employees and culture remain critical to our success,” says Dr. Albrecht Kissel, president and CEO of BIVI. “Collaboration, diversity, innovation, mutual respect—these are a few of the qualities we are proud of and help make BIVI a great place to work.”

Locally, BIVI is celebrating its award with Missouri employees with a surprise thank-you event with t-shirts depicting the Missouri Best Places to Work logo and doughnuts.

About Boehringer Ingelheim

Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates and more than 47,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

Social responsibility is a central element of Boehringer Ingelheim’s culture. Involvement in social projects, caring for the employees and their families and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors of all Boehringer Ingelheim’s endeavors.

With nearly 3,000 employees worldwide, Boehringer Ingelheim Animal Health achieved net sales of about $1.46 billion (1.07 billion euros) in 2013. In our research-driven Animal Health business, Boehringer Ingelheim continually invests more than 10% of net sales of the Animal Health business in R&D.